DIC score in pregnant women - A population based modification of the international society on thrombosis and hemostasis score

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Erez, Offer ^a   Novack, Lena ^b   Beer Weisel, Ruthy ^a   Dukler, Doron ^a   Press, Fernanda ^a   Zlotnik, Alexander ^a   Than, Nandor Gabor ^c   Tomer, Aaron ^a   Mazor, Moshe ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN;

ADULT; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DISSEMINATED INTRAVASCULAR COAGULATION SCORE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; ISRAEL; MAJOR CLINICAL STUDY; MALE; NEWBORN; NOMOGRAM; PARTIAL THROMBOPLASTIN TIME; POPULATION RESEARCH; PREGNANCY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; VALIDATION STUDY; DISSEMINATED INTRAVASCULAR COAGULATION; HEMOSTASIS; METABOLISM; THROMBOSIS;

DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; PREGNANCY; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 84899623276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093240     Document Type: Article

References (84)

1. Hahn L (1974) On fibrinolysis and coagulation during parturition and menstruation. Acta Obstet Gynecol Scand Suppl 28: 7-40.
2. Brenner B, Aharon A, Lanir N (2005) Hemostasis in normal pregnancy. Thromb Res 115 Suppl 1: 6-10.
3. Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114: 409-14.
4. Lockwood CJ, Krikun G, Schatz F (1999)The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 17: 45-51.
5. Lockwood CJ, Krikun G, Schatz F (2001) Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann N Y Acad Sci 943: 77-88.
6. Erez O, Gotsch F, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, et al. (2009)Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med 22: 672-87.
7. Lockwood CJ, Bach R, Guha A, Zhou XD, Miller WA, et al. (1991) Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 165: 1335-41.
8. Uszynski M, Zekanowska E, Uszynski W, Kuczynski J (2001) Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 95: 163-66.
9. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW (1984) Haemostasis in normal pregnancy. Thromb Haemost 52: 176-82.
10. Beller FK, Ebert C (1982) The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol 13: 177-97.
11. Donohoe S, Quenby S, Mackie I, Panal G, Farquharson R, et al. (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. Lupus 11: 11-20.
12. Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16: 153-68.
13. Hellgren M, Blomback M (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 12: 141-54.
14. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, et al. (1998) Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 79: 1166-70.
15. Faught W, Garner P, Jones G, Ivey B (1995) Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 172: 147-50.
16. Oruc S, Saruc M, Koyuncu FM, Ozdemir E (2000) Changes in the plasma activities of protein C and protein S during pregnancy. Aust N Z J Obstet Gynaecol 40: 448-50.
17. Lefkowitz JB, Clarke SH, Barbour LA (1996) Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 175: 657-60.
18. Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, et al. (2007)Hae-Haemostatic changes and acquired activated protein C resistance in normal pregnancy. Blood Coagul Fibrinolysis 18: 685-88.
19. Mimuro S, Lahoud R, Beutler L, Trudinger B (1998) Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation. Aust N Z J Obstet Gynaecol 38: 200-04.
20. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, et al. (1995)Develop-Development of resistance to activated protein C during pregnancy. Br J Haematol 90: 725-27.
21. BIEZENSKI JJ, MOORE HC (1958) Fibrinolysis in normal pregnancy. J Clin Pathol 11: 306-10.
22. NAIDOO SS, HATHORN M, GILLMAN T (1960) Fibrinolytic and antifibrinolytic activity in pregnancy. J Clin Pathol 13: 224-5.
23. Thorsen S (1973) The inhibition of tissue plasminogen activator and urokinaseinduced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects. Scand J Clin Lab Invest 31: 51-59.
24. Arias F, Andrinopoulos G, Zamora J (1979) Whole-blood fibrinolytic activity in normal and hypertensive pregnancies and its relation to the placental concentration of urokinase inhibitor. Am J Obstet Gynecol 133: 624-29.
25. Kline JA, Williams GW, Hernandez-Nino J (2005) D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem 51: 825-29.
26. Berg CJ, Callaghan WM, Syverson C, Henderson Z (2010) Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 116: 1302-09.
27. Walfish M, Neuman A, Wlody D (2009) Maternal haemorrhage. Br J Anaesth 103 Suppl 1:i47-56.
28. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327-30.
29. Terao T, Maki M, Ikenoue T (1987) A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC. Asia Oceania J Obstet Gynaecol 13: 1-13.
30. Levi M (2009)Disseminated intravascular coagulation in cancer patients. Best Pract Res Clin Haematol 22: 129-36.
31. Levi M (2007) Disseminated intravascular coagulation. Crit Care Med 35: 2191-95.
32. Levi M (2005)Pathogenesis and treatment of DIC. Thromb Res 115 Suppl 1: 54-5.
33. Levi M, de Jonge E, van der Poll T (2003) Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 16: 43-47.
34. Levi M (2001) Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. J Crit Care 16: 167-77.
35. Cauchie P, Cauchie C, Boudjeltia KZ, Carlier E, Deschepper N, et al. (2006) Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital-meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. Am J Hematol 81: 414-19.
36. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, et al. (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101: 816-23.
37. Gando S, Kameue T, Nanzaki S, Nakanishi Y (1996) Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75: 224-28.
38. Gando S, Kameue T, Matsuda N, Sawamura A, Hayakawa M, et al. (2004) Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Inflammation 28: 237-44.
39. Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, et al. (2008) Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 36: 145-50.
40. Levi M, van der Poll T (2013) Disseminated intravascular coagulation: a review for the internist. Intern Emerg Med 8: 23-32.
41. Levi M, ten Cate H, van der Poll T, van Deventer SJ (1993)Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270: 975-79.
42. Levi M (2009) Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period. Thromb Res 123 Suppl 2:S63-4.
43. Thachil J, Toh CH (2009) Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 23: 167-76.
44. Romero R, Kadar N, Vaisbuch E, Hassan SS (2010) Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol 64: 113-25.
45. Rattray DD, O'Connell CM, Baskett TF (2012)Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 34: 341-47.
46. Montagnana M, Franchi M, Danese E, Gotsch F, et al. (2010) Disseminated intravascular coagulation in obstetric and gynecologic disorders. Semin Thromb Hemost 36: 404-18.
47. Lurie S, Feinstein M, Mamet Y (2000) Disseminated intravascular coagulopathy in pregnancy: thorough comprehension of etiology and management reduces obstetricians' stress. Arch Gynecol Obstet 263: 126-30.
48. Liao WC, Jaw FS (2011) A noninvasive evaluation analysis of amniotic fluid embolism and disseminated intravascular coagulopathy. J Matern Fetal Neonatal Med 24: 1411-15.
49. Levi M (2013)Pathogenesis and management of peripartum coagulopathic calamities (disseminated intravascular coagulation and amniotic fluid embolism). Thromb Res 131 Suppl 1:S32-4.
50. Gasem T, Al Jama FE, Burshaid S, Rahman J, Al Suleiman SA, et al. (2009) Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Matern Fetal Neonatal Med 22: 1140-43.
51. Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H (1983) Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol 265-75.
52. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, et al. (2006) A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34: 625-31.
53. Angstwurm MW, Dempfle CE, Spannagl M (2006) New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores. Crit Care Med 34: 314-20.
54. Asakura H, Wada H, Okamoto K, Iba T, Uchiyama T, et al. (2006) Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections. Thromb Haemost 95: 282-87.
55. Bakhtiari K, Meijers JC, de Jonqe E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32: 2416-21.
56. Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N (2007) Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand 86: 648-51.
57. Sundberg E, Hultdin J, Nilsson S, Ahlm C (2006) Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One 6:e21134.
58. Park KS, Choi KH, Kim YS, Hong BS, Kim OY, et al. (2010) Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One 2010 5:e11334.
59. Ganrot PO. (1972) Variation of the concentrations of some plasma proteins in normal adults, in pregnant women and in newborns. Scand J Clin Lab Invest Suppl 124: 83-8.
60. van Buul EJ, Steegers EA, Jongsma HW, Eskes TK, Thomas CM, et al. (1995)Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med 46: 73-85.
61. Hansen AT, Andreasen BH, Salvig JD, Hvas AM (2011) Changes in fibrin Ddimer, fibrinogen, and protein S during pregnancy. Scand J Clin Lab Invest 71: 173-76.
62. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, et al. (1997) Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 73: 31-36.
63. Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, et al.(2010) Haemostatic reference intervals in pregnancy. Thromb Haemost 103: 718-27.
64. Francalanci I, Comeglio P, Liotta AA, Cellai AP, Fedi S, et al. (1995) D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 78: 399-405.
65. Muller-Berghaus G, Moeller RM, Mahn I (1978) Fibrinogen turnover in pregnant rabbits during the first and last thirds of gestation. Am J Obstet Gynecol 131: 655-60.
66. Spero JA, Lewis JH, Hasiba U (1980) Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 43: 28-33.
67. Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145: 24-33.
68. Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29: 125-30.
69. Tygart SG, McRoyan DK, Spinnato JA, McRoyan CJ, Kitay DZ (1986) Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol 154: 883-87.
70. Erez O, Wiznitzer A, Mazor M (2000) Thrombocytopenia in pregnancy. Harefuah 139: 292-98.
71. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, et al. (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169: 1000-06.
72. Martin JN Jr, Rinehart BK, May WL, Magann EF, Terrone DA, et al. (1999) The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 180: 1373-84.
73. Martin JN Jr, Brewer JM, Wallace K, Sunesara I, Canizaro A, et al. (2013) HELLP syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med 26: 1201-06.
74. Martin JN Jr (2013) Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). Int J Gynaecol Obstet 121: 202-07.
75. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF,et al. (1999) Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 181: 924-28.
76. Haddad B, Barton JR, Livingston JC, Chahine R, Sibai BM (2000) Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 183: 444-48.
77. Chakraverty R, Davidson S, Peggs K, Stross P, Garrard C, et al. (1996)The incidence and cause of coagulopathies in an intensive care population. Br J Haematol 93: 460-63.
78. Levi M, Meijers JC (2011)DIC: which laboratory tests are most useful. Blood Rev 25: 33-37.
79. Hatada T, Wada H, Kawasugi K, Okamoto K, Uchiyama T, et al. (2012) Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC. Clin Appl Thromb Hemost 18: 495-500.
80. Brown MD, Rowe BH, Reeves MJ, Bermingham JM, Goldhaber SZ (2002) The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. Ann Emerg Med 40: 133-44.
81. Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, et al. (2004) D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 140: 589-602.
82. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism (2003) Thorax 58: 470-83.
83. Voves C, Wuillemin WA, Zeerleder S (2006) International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis 17: 445-51.
84. Rizoli S, Nascimento B Jr, Key N, Tien HC, Muraca S, et al. (2011) Disseminated intravascular coagulopathy in the first 24 hours after trauma: the association between ISTH score and anatomopathologic evidence. J Trauma 71: S441-S447.